InvestorsObserver
×
News Home

Abbott Laboratories (ABT) is higher by 0.68% in a Week, Should You Accumulate?

Thursday, November 18, 2021 01:22 PM | InvestorsObserver Analysts

Mentioned in this article

Abbott Laboratories (ABT) is higher by 0.68% in a Week, Should You Accumulate?

Abbott Laboratories (ABT) is near the top in its industry group according to InvestorsObserver. ABT gets an overall rating of 68. That means it scores higher than 68 percent of stocks. Abbott Laboratories gets a 96 rank in the Medical Devices industry. Medical Devices is number 86 out of 148 industries.

Overall Score - 68
ABT has an Overall Score of 68. Find out what this means to you and get the rest of the rankings on ABT!

What do These Ratings Mean?

Finding the best stocks can be tricky. It isn’t easy to compare companies across industries. Even companies that have relatively similar businesses can be tricky to compare sometimes. InvestorsObserver’s tools allow a top-down approach that lets you pick a metric, find the top sector and industry and then find the top stocks in that sector. These rankings allows you to easily compare stocks and view what the strengths and weaknesses are of a given company. This lets you find the stocks with the best short and long term growth prospects in a matter of seconds. The combined score incorporates technical and fundamental analysis in order to give a comprehensive overview of a stocks performance. Investors who then want to focus on analysts rankings or valuations are able to see the separate scores for each section.

What's Happening With Abbott Laboratories Stock Today?

Abbott Laboratories (ABT) stock is down -0.4% while the S&P 500 has risen 0.3% as of 1:18 PM on Thursday, Nov 18. ABT is down -$0.51 from the previous closing price of $128.62 on volume of 1,350,626 shares. Over the past year the S&P 500 is up 31.81% while ABT has risen 16.71%. ABT earned $4.05 a per share in the over the last 12 months, giving it a price-to-earnings ratio of 31.68. Click Here to get the full Stock Report for Abbott Laboratories stock.

You May Also Like

Get the InvestorsObserver App

InvestorsObserver App
iOS App Android App